Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noor Atatreh

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Drug Design, Development and Therapy|August 9, 2022
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsLara Alzyoud, Mohammad A Ghattas, Noor Atatreh
Journal of Enzyme Inhibition and Medicinal Chemistry|February 6, 2025
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffoldsNoor Atatreh, Radwa E Mahgoub, Mohammad A Ghattas
Journal of Chemical Information and Modeling|July 7, 2020
How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics StudyMohammad A Ghattas, Sara Al Rawashdeh, Noor Atatreh, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 19, 2023
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main proteaseNoor Atatreh, Shaima Hasan, Bassam R Ali, et al.
Chemical Biology & Drug Design|August 12, 2015
Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric SiteMohammad A Ghattas, Ramez A Mansour, Noor Atatreh, et al.
Drug Design, Development and Therapy|October 21, 2016
Druggability analysis and classification of protein tyrosine phosphatase active sitesMohammad A Ghattas, Noor Raslan, Asil Sadeq, et al.
Journal of Molecular Graphics & Modelling|July 20, 2014
Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screeningMohammad A Ghattas, Noor Atatreh, Elena V Bichenkova, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|October 20, 2025
Curcumin Derivatives as Allosteric Modulator of α7-nAChR: Functional and Molecular Docking InsightsEslam ElNebrisi, Mohammad A Ghattas, Noor Atatreh, et al.
Pharmacy Practice|February 16, 2023
Assessing adherence to medications: Is there a difference between a subjective method and an objective method, or between using them concurrently?Razan I Nassar, Bandana Saini, Nathir M Obeidat, et al.
Scientific Reports|May 13, 2022
Structure-based assessment and druggability classification of protein-protein interaction sitesLara Alzyoud, Richard A Bryce, Mohammad Al Sorkhy, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Drug Design, Development and Therapy|August 9, 2022
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus AgentsLara Alzyoud, Mohammad A Ghattas, Noor Atatreh
Journal of Enzyme Inhibition and Medicinal Chemistry|February 6, 2025
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffoldsNoor Atatreh, Radwa E Mahgoub, Mohammad A Ghattas
Journal of Chemical Information and Modeling|July 7, 2020
How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics StudyMohammad A Ghattas, Sara Al Rawashdeh, Noor Atatreh, et al.
Acta Pharmaceutica (Zagreb, Croatia)|January 19, 2023
Computer-aided approaches reveal trihydroxychroman and pyrazolone derivatives as potential inhibitors of SARS-CoV-2 virus main proteaseNoor Atatreh, Shaima Hasan, Bassam R Ali, et al.
Chemical Biology & Drug Design|August 12, 2015
Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric SiteMohammad A Ghattas, Ramez A Mansour, Noor Atatreh, et al.
Drug Design, Development and Therapy|October 21, 2016
Druggability analysis and classification of protein tyrosine phosphatase active sitesMohammad A Ghattas, Noor Raslan, Asil Sadeq, et al.
Journal of Molecular Graphics & Modelling|July 20, 2014
Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screeningMohammad A Ghattas, Noor Atatreh, Elena V Bichenkova, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|October 20, 2025
Curcumin Derivatives as Allosteric Modulator of α7-nAChR: Functional and Molecular Docking InsightsEslam ElNebrisi, Mohammad A Ghattas, Noor Atatreh, et al.
Pharmacy Practice|February 16, 2023
Assessing adherence to medications: Is there a difference between a subjective method and an objective method, or between using them concurrently?Razan I Nassar, Bandana Saini, Nathir M Obeidat, et al.
Scientific Reports|May 13, 2022
Structure-based assessment and druggability classification of protein-protein interaction sitesLara Alzyoud, Richard A Bryce, Mohammad Al Sorkhy, et al.
Pageof 4